Get the Stockscreener App
180.62
5.21%
8.94
After Hours:
178.58
-2.04
-1.13%
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $180.62, with a volume of 5.93M.
It is up +5.21% in the last 24 hours and down -10.91% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$171.68
Open:
$170.67
24h Volume:
5.93M
Relative Volume:
2.65
Market Cap:
$51.41B
Revenue:
$21.92B
Net Income/Loss:
$1.76B
P/E Ratio:
29.50
EPS:
6.1223
Net Cash Flow:
$2.63B
1W Performance:
-13.11%
1M Performance:
-10.91%
6M Performance:
-6.17%
1Y Performance:
-21.31%
1-Day Range:
$170.67
$182.00
1-Week Range:
$164.41
$211.47
52-Week Range:
$162.29
$235.34
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
180.62 | 48.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ISRG
Intuitive Surgical Inc
|
496.12 | 175.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
ALC
Alcon Inc
|
79.39 | 39.53B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.62 | 38.39B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
45.04 | 37.69B | 27.43B | 1.27B | 1.01B | 1.5829 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Becton Dickinson & Co (BDX) Shares Up 3.75% on Feb 11 - GuruFocus
Becton Dickinson (BDX): Citigroup Maintains Rating but Lowers Pr - GuruFocus
Are Wall Street Analysts Bullish on Becton, Dickinson and Company Stock? - Yahoo Finance
Jensen Investment Management Inc. Lowers Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Purchased by Midwest Trust Co - MarketBeat
Becton Dickinson price target lowered to $172 by RBC Capital - Investing.com South Africa
Becton Dickinson (BDX) Gains Overweight Rating from Barclays - GuruFocus
Becton Dickinson Launches $1.6 Billion Debt Tender Offers - TipRanks
Jefferies Lowers Price Target for Becton Dickinson (BDX) to $190 - GuruFocus
Jefferies Financial Group Cuts Becton, Dickinson and Company (NYSE:BDX) Price Target to $190.00 - MarketBeat
TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $189 - 富途牛牛
What's Going On With Becton Dickinson Stock Tuesday?Becton Dickinson (NYSE:BDX) - Benzinga
Becton, Dickinson Launches $1.6 Billion Tender Offers; Shares Rise - marketscreener.com
Becton Dickinson and Co (NYSE:BDX) Lowers Profit Guidance - FXDailyReport.Com
BD Launches Cash Tender Offers for Debt Securities - Intellectia AI
Jim Cramer on Becton, Dickinson: "I Kind of Really Like the New Company" - Finviz
Wells Fargo Lowers Price Target for Becton Dickinson (BDX) | BDX Stock News - GuruFocus
Jim Cramer on Becton, Dickinson: “I Kind of Really Like the New Company” - Insider Monkey
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $202 - 富途牛牛
Becton, Dickinson and Company (NYSE:BDX) Shares Gap Down After Analyst Downgrade - MarketBeat
Becton Dickinson (BDX) Options Delisted Effective February 10th - GuruFocus
Becton Dickinson (BDX) Faces Market Reaction Post Life Sci Trans - GuruFocus
Wells Fargo & Company Cuts Becton, Dickinson and Company (NYSE:BDX) Price Target to $157.00 - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Price Target Cut to $175.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
Piper Sandler lowers Becton Dickinson stock price target on growth concerns - Investing.com
Becton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination - Seeking Alpha
Becton, Dickinson and Company (NYSE:BDX) Q1 2026 Earnings Call Transcript - Insider Monkey
Piper Sandler Adjusts Becton, Dickinson and Company Price Target to $170 From $205, Maintains Neutral Rating - marketscreener.com
Jefferies lowers Becton Dickinson stock price target to $190 on separation - Investing.com Nigeria
Jefferies lowers Becton Dickinson stock price target to $190 on separation By Investing.com - Investing.com South Africa
Citi Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $232 - 富途牛牛
JPMorgan Adjusts PT on Becton, Dickinson and Co. to $175 From $190, Maintains Neutral Rating - marketscreener.com
Jefferies Adjusts PT on Becton, Dickinson and Co. to $190 From $220, Maintains Buy Rating - marketscreener.com
Beyond the Balance Sheet: What SWOT Reveals About Becton Dickins - GuruFocus
Becton, Dickinson and Company (BDX) Completes Strategic Spin-Off and Merger with Waters Corporation - GuruFocus
Becton, Dickinson Earnings Call: Growth Amid Tariff Drag - TipRanks
Becton Dickinson Q1 FY26 slides: Revenue beats expectations amid margin pressure - Investing.com Nigeria
Becton Dickinson's stock price suffered a cliff-like drop, plunging by 19.8%, heading toward its worst single-day decline since 1999. - Bitget
Becton Dickinson & Co (BDX) Q1 2026 Earnings Call Highlights: Strong Performance Amid ... By GuruFocus - Investing.com Canada
Update: Becton Dickinson Fiscal Q1 Adjusted Earnings Fall, Revenue Rises; Shares Fall - 富途牛牛
Becton Dickinson & Co (BDX) Q1 2026 Earnings Call Highlights: St - GuruFocus
BD Completes Sale of Biosciences & Diagnostic Solutions to Waters - Medical Product Outsourcing
Waters Corp Shares Fall After Low Profit Outlook, Closing of Becton Dickinson Unit Deal - 富途牛牛
BD beats Street in ‘stronger-than-expected’ Q1 performance - MassDevice
Becton Dickinson stock falls as RBC maintains Sector Perform rating By Investing.com - Investing.com Nigeria
BD Completes Spin-Off of Biosciences & Diagnostic Solutions, Combines With Waters - citybiz
Becton Dickinson Q1 FY26 slides: Revenue beats expectations amid margin pressure By Investing.com - Investing.com India
BD (BDX) Shares Dip Despite Beating Q1 Expectations - GuruFocus
Earnings call transcript: Becton Dickinson Q1 2026 beats expectations, stock dips - Investing.com India
Becton, Dickinson and Company Q1 Earnings Call Highlights - MarketBeat
Dow Falls 250 Points; Becton Dickinson Posts Upbeat Earnings - Benzinga
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):